Saturday, Mar 06, 2021 - 07:01:07
14 results - (0.000 seconds)

to mass produce:

    Apple could start manufacturing iPads in Vietnam by the middle of this year, marking the first time a “significant number” of the tablets would be produced outside of China, Nikkei reports. As well as shifting iPad production, Apple is also reportedly increasing the number of iPhones manufactured in India, where it’s produced some iPhone 11 units since last year. It will reportedly begin producing iPhone 12 series devices in the country as early as this quarter. The report paints a picture of a company that’s increasingly keen to diversify its manufacturing out of China, despite hopes that trade tensions could ease under President Biden. Nikkei notes that the new administration has said it won’t immediately ease tariffs on Chinese imports, and there are also other factors like rising labor costs in China prompting Apple and other companies to look for alternative manufacturing hubs. More audio products could be produced in...
    BALTIMORE (WJZ) — A Baltimore-based company is gearing up to mass-produce a COVID-19 vaccine once it’s approved. Inside Emergent BioSolutions, employees are ramping up their efforts, anticipating the approval of a COVID-19 vaccine. Sean Kirk is the Executive Vice President of Manufacturing. He said the facility will make the bulk of the vaccine and ship it out to be filled into the vials that many people are used to seeing in a clinic. CORONAVIRUS COVERAGE: TIMELINE: Coronavirus In Maryland, Tracking The Spread Latest coronavirus stories from WJZ Latest CDC Guidelines The company is the primary North American manufacturer for the AstraZeneca and Johnson & Johnson vaccine candidates. Although, if need be, Emergent BioSolutions is able to support other vaccine candidates, too. “We have a great, talented workforce from the Baltimore-area and we are leveraging that talent in the fight against COVID each and every day,” Kirk said. Over...
    A blood sample is prepared for analysis by a laboratory technician at Accel Research Sites on August 4, 2020 in DeLand, Florida, U.S.NurPhoto | NurPhoto | Getty Images Moderna's announcement earlier this week that its vaccine was more than 94% effective at preventing the coronavirus, according to preliminary trial data, raised global hopes further that a resolution to the pandemic that has killed over 1.3 million could be in sight. The news followed on from Pfizer and BioNTech's equally positive news that their vaccine candidate was over 90% effective. The news from Moderna was hailed as a "game changer" and Pfizer's chief executive described the vaccine achievement as "a great day for science and humanity." As the market revelry at the news continued, attention quickly turned to practical matters given the unprecedented logistical challenge posed by producing and distributing vaccines, should they receive final regulatory approval, to a global population of...
    A South Korean biotechnology company and the Russian Direct Investment Fund have entered into an agreement to produce more than 150 million doses of Russia's Sputnik V coronavirus vaccine. The fund said Friday that it has partnered with GL Rapha to produce 150 million doses per year and distribute them globally. Production will begin in December in South Korea, India, Brazil and China, among other countries, with distribution starting in January.Cartoons on the CoronavirusView All 422 ImagesRussia claims that phase three trials of Sputnik V have shown it to be 92% effective against COVID-19 based on 20 confirmed virus cases split between people who received the vaccine and those who received a placebo.The Russian Direct Investment Fund in a press release calls Sputnik V "the world's first registered vaccine against the novel coronavirus infection." The fund says that 40,000 people are currently taking part in clinical trials...
    Virtually every semi-autonomous car you’ve seen on the road, even Teslas with Autopilot, uses level 2 self-driving — they may save you from steering or hitting the accelerator, but they won’t make many decisions by themselves. Honda believes it will push those boundaries, however. According to Reuters, the transportation giant claims it will be the first to mass produce cars with level 3 self-driving. While you’ll still have to be ready to take over, the cars could make important decisions like overtaking slow cars. Honda’s first level 3 vehicle will be a version of its Legend sedan (pictured above) equipped with a Traffic Jam Pilot feature. It should arrive before the end of the company’s fiscal year, or no later than March 2021.
    As the months ticked by and the pandemic pressed on, Richmond entrepreneur Wendy Scelia felt called to help as many people as she could by finding a way to mass produce protective face masks. Scelia’s second startup venture, Olivian, was born earlier this summer out of her desire to help replenish the county’s domestic mask supply in response to PPE shortages around the globe. Scelia, who also founded hospitality software firm Tablee, said she first considered the idea after her step-brother’s wife, the head of nursing at a Connecticut hospital, struggled to supply her staff with enough PPE during the early days of Covid. “She was writing procedures that called for her nurses to reuse the disposable face masks because they just didn’t have enough,” she said. “And I thought, ‘Oh my God. There’s got to be something I can do to help.'” She first used her overseas connections...
    Indian Prime Minister Narendra Modi said his country was prepared to mass produce a coronavirus vaccine the moment it was ready. “Not one, not two, as many as three coronavirus vaccines are being tested in India,” he said during an Independence Day speech in Delhi Saturday, Reuters reported. “Along with mass-production, the roadmap for distribution of vaccine to every single Indian in the least possible time is also ready,” India has recorded more than 2.5 million coronavirus cases and suffered almost 50,000 deaths. During the festivities, which took place at the city’s 17th century “Red Fort,” the prime minister took his own COVID-19 precautions covering his mouth with an orange and white scarf whenever he was approached. The 4,000 invited guests were spaced six feet apart and the entire event was flanked by ambulances and medical booths for anyone who felt unwell. Filed under Coronavirus ,  india ,  narendra modi...
    NEW DELHI (Reuters) - India is ready to mass produce COVID-19 vaccines to distribute across the country when scientists give the go-ahead to do so, Prime Minister Narendra Modi said in his Independence Day speech on Saturday. "Not one, not two, as many as three coronavirus vaccines are being tested in India," he said from the ramparts of the Red Fort in the old quarters of Delhi. "The country is also ready for mass production of those vaccines." (Reporting by Abhirup Roy, Aftab Ahmed and Krishna N. Das; Editing by Shri Navaratnam) Copyright 2020 Thomson Reuters.
    Need to stay updated on coronavirus news in Texas? Our evening roundup will help you stay on top of the day’s latest updates. Sign up here. A biotech production facility in College Station could begin manufacturing a COVID-19 vaccine as early as next year. As part of a $265 million contract with the federal government, the Texas A&M University System Center for Innovation in Advanced Development and Manufacturing — which is owned and operated by Fujifilm Diosynth Biotechnologies — has been tapped to mass-manufacture a vaccine candidate that is still undergoing testing. That vaccine, which is being developed by the little-known Maryland company Novavax, is one of six candidates the federal government has put billions of dollars behind as part of its Operation Warp Speed, which is pursuing an aggressive timeline for mass-distributing a coronavirus vaccine. President Donald Trump, appearing Monday afternoon at a North Carolina Fujifilm facility where the...
    Chinese companies are using a state-run labor program to force its mostly Muslim Uighur minorities into manufacturing masks and other personal protective equipment to keep up with increased demands during the coronavirus pandemic, an investigation by the New York Times said Sunday. Though most of the gear purportedly produced through Uighur forced labor was distributed domestically, some Chinese companies that participated in the work transfer program also sent out shipments on the global market to countries, including the United States. At least one shipment was sent to a medical supply company in Georgia from a factory in China’s Hubei Province, where more than 100 Uighur workers were assigned, according to the Times. The work transfer program involves shipping Uighur workers from their homes in the Xinjiang region to factories and other service jobs. They are required to learn Mandarin and pledge their allegiance to China at weekly flag-raising ceremonies. Workers...
    China is forcing Uighur labour to mass produce face masks as part of the country's Muslim 're-education' programme during the coronavirus pandemic, a report has revealed. Chinese companies are using Uighur workers through a controversial government-sponsored programme which experts say often involves forced labour, according to a New York Times investigation. It comes as Britain accused Beijing of 'gross, egregious human rights abuses' over its 'deeply troubling' treatment of ethnic and religious minorities in Xinjiang. China has refuted the allegations. China is forcing Uighur workers to mass produce face masks as part of the country's Muslim 're-education' programme during the coronavirus pandemic, report says. The file picture taken on June 18 shows workers at a garment factory in Aketao county of the Uighur region Xinjiang RELATED ARTICLES Previous 1 Next China warns Britain 'will bear the consequences' of... China warns Britain against going down the 'wrong path'...
    Chinese companies are using a state-run labor program to force its mostly Muslim Uighur minorities into manufacturing masks and other personal protective equipment to keep up with increased demands during the coronavirus pandemic, an investigation by the New York Times said Sunday. Though most of the gear purportedly produced through Uighur forced labor was distributed domestically, some Chinese companies that participated in the work transfer program also sent out shipments on the global market to countries, including the United States. At least one shipment was sent to a medical supply company in Georgia from a factory in China’s Hubei Province, where more than 100 Uighur workers were assigned, according to the Times. CHINA SUBJECTS MUSLIM MINORITIES TO FORCED BIRTH CONTROL, ABORTIONS TO SUPPRESS POPULATION, REPORT SAYS  A perimeter fence is constructed around what is officially known as a vocational skills education center in Dabancheng in Xinjiang...
    SANTIAGO, Chile (AP) — Nicolás Bergerie’s family has been making coffins for four generations, with barely any alteration. But when he saw the coronavirus ravaging Europe, he decided to roll out a new product. The “COVID” is a casket that eliminates precious woods, detailed carvings and glass viewing panes in favor of a plain box of cheaper wood that is fast to produce in quantity. It’s the perfect product for Chile, which has become a hot spot for the virus despite aggressive government measures to control its spread. On Friday, Chile’s 230,000 cases made it ninth in the world in the number of confirmed coronavirus infections, despite its relatively small population of fewer than 19 million people. With more than 5,000 new cases reported on a typical day, next week Chile is expected to pass Italy in the ranks of most-infected countries. With more than 4,000 dead...
1